Engineering a TCR-like Anti-PR1/HLA-A2 Antibody Scfv in a Novel Chimeric Antigen Receptor (CAR) to Redirect T Cells to Eliminate Myeloid Leukemia
2016
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI